195 related articles for article (PubMed ID: 36012726)
1. From Dukes-MAC Staging System to Molecular Classification: Evolving Concepts in Colorectal Cancer.
Banias L; Jung I; Chiciudean R; Gurzu S
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012726
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition.
Banias L; Jung I; Bara T; Fulop Z; Simu P; Simu I; Satala C; Gurzu S
Oncol Lett; 2020 Feb; 19(2):1487-1495. PubMed ID: 31966075
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
4. C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.
Oshiro R; Yamamoto H; Takahashi H; Ohtsuka M; Wu X; Nishimura J; Takemasa I; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
Cancer Sci; 2012 Jun; 103(6):1155-64. PubMed ID: 22404718
[TBL] [Abstract][Full Text] [Related]
5. A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer.
Roseweir AK; Kong CY; Park JH; Bennett L; Powell AGMT; Quinn J; van Wyk HC; Horgan PG; McMillan DC; Edwards J; Roxburgh CS
Int J Cancer; 2019 Jan; 144(1):150-159. PubMed ID: 29992570
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
7. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
Luo W; Fang W; Li S; Yao K
Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the Glasgow Microenvironment Score and markers of epithelial-mesenchymal transition in TNM II-III colorectal cancer.
Alexander PG; Matly AAM; Jirapongwattana N; Pennel KAF; van Wyk HC; McMillan DC; Horgan PG; Roxburgh CSD; Thuwajit C; Roseweir AK; Quinn J; Park JH; Edwards J
Hum Pathol; 2022 Sep; 127():1-11. PubMed ID: 35623467
[TBL] [Abstract][Full Text] [Related]
10. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
Jang TJ
Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
[TBL] [Abstract][Full Text] [Related]
11. Validation of a new classification system for curatively resected colorectal adenocarcinoma.
Sternberg A; Sibirsky O; Cohen D; Blumenson LE; Petrelli NJ
Cancer; 1999 Sep; 86(5):782-92. PubMed ID: 10463976
[TBL] [Abstract][Full Text] [Related]
12. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
[TBL] [Abstract][Full Text] [Related]
14. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
[TBL] [Abstract][Full Text] [Related]
15. [A systematic review of worldwide natural history models of colorectal cancer: classification, transition rate and a recommendation for developing Chinese population-specific model].
Li ZF; Huang HY; Shi JF; Guo CG; Zou SM; Liu CC; Wang Y; Wang L; Zhu SL; Wu SL; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):253-260. PubMed ID: 28231677
[No Abstract] [Full Text] [Related]
16. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
[TBL] [Abstract][Full Text] [Related]
18. The correlation of epithelial-mesenchymal transition-related gene expression and the clinicopathologic features of colorectal cancer patients in Taiwan.
Dai YC; Fang CY; Yang HY; Jian YJ; Wang SC; Liu YW
PLoS One; 2021; 16(7):e0254000. PubMed ID: 34214117
[TBL] [Abstract][Full Text] [Related]
19. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
